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ABSTRACT
￿
Prolactin (PRL) gene expression in three strains of GH cells (rat pituitary tumor cells)
has been quantitated by measurement of: (a) intracellular and extracellular PRL, (b) cytoplasmic
translatable PRL-specific mRNA (mRNAPRL), and (c) molecular hybridization of cytoplasmic
poly(A) RNA to cDNAPRL (DNA complementary to mRNAPRL). Three GH cell lines utilized in
this investigation were a PRL-producing (PRL+ ) strain, GH4C,, a PRL nonproducing 5-bromo-
deoxyuridine resistant (PRL- BrdUrd') strain, F,BGH,2C,, and a new strain, 928-9b, derived by
fusion of PRL+ cells with a nuclear monolayer of the PRL- , BrdUrdr GH cell strain . PRL
production is a characteristic of 928-9b cells, but the level of PRL production (2-4 Ftg/mg
protein/24 h) is much lower than that of the PRL+ strain, GH4C, (15-25 ,ug/mg protein/24 h) .
Levels of cytoplasmic translatable mRNAPRL and cytoplasmic PRL-RNA sequences quantitated
with a cDNAPRL probe were also much lower in 928-9b as compared to the PRL+ parent. PRL-
RNA sequences could not be detected in the PRL- strain . Thyrotropin-releasing hormone (TRH)
stimulates PRL synthesis about threefold and inhibits growth hormone (GH) synthesis 72% in
the PRL+ strain . TRH has no effect on the synthesis of either PRL or GH in the 928-9b strain,
although TRH receptors could be detected in these cells. Stimulation of PRL synthesis in the
PRL+ strain by TRH could be correlated with increases in levels of cytoplasmic translatable
mRNAPRL and increases in cytoplasmic PRL-RNA sequences. These results demonstrate that the
graded expression of the PRL gene at the basal level, and in response to TRH, is caused by the
regulated production of specific mRNA, i.e., mRNAPRL in these three GH cell strains.
Different clonal strains of rat pituitary tumor cells (GH cells)
in culture produce different amounts oftwo protein hormones,
prolactin (PRL) and growth hormone (GH). Certain properties
of the GH strains used in this investigation are described in
Table I. The GH strains differ from each other not only in
their basal level production of PRL but also in their response
to the physiological modulator, thyrotropin-releasing hormone
(TRH) and to the drug, 5-bromodeoxyuridine (BrdUrd) (l, 2).
The GH,C, and GH3 subclones respond to TRH with a
stimulation ofPRL synthesis and an inhibition of GH synthesis
(for review, see reference 13.). However, GH12C1 and the
BrdUrd' (BrdUrd resistant) derivative of GH12C1 , the
F,BGH12C, substrain, do not produce any detectable PRL and
do not respond to TRH. We have previously reported that
PRL synthesis can be induced in these two PRL-nonproducing
(PRL-) strains by treatment with the drug BrdUrd (1). These
results suggest that, in these cells, PRL synthesis is under the
influence of a rigid cellular control mechanism/s which does
6
not permit PRL gene expression, but which is affected by
incorporation of the drug into the DNA, subsequently permit-
ting the PRL gene to be expressed.
The varied basal level expression of the PRL gene in these
GH strains and the varied responses of the cells to modulators
such as TRH and BrdUrd, constitutes a system in which a
specific eukaryotic gene can be regulated to different degrees
under steady-state conditions and can be further modulated in
response to physiological and pharmacological agents (6, 8, 9,
15).
In this investigation, a comparative study of the properties
of the PRL+ and PRL- parent GH cells and of the substrain
derived from these two strains, has been made. Several char-
acteristics of these three GH strains such as (a) level of PRL
and GH production, (b) TRH response, and (c) presence of
TRH receptors and BrdUrd induction were examined (Table
I "?"). A probe into the different steps, involved in varied PRL
production by the two parent strains and by the progeny at
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clarify the molecular mechanism/s involved in PRL gene
regulation in these cells.
MATERIALS AND METHODS
Cells and Growth Conditions
GH Cells are clonal strains of rat pituitary tumor cells (l8). Properties of
different GH cell strains used in this investigation are described in Table 1. Cells
were generally grown in monolayer culture with complete F10 medium (Ham's
F10 medium supplemented with 15% horse serum and 2.5% fetal calfserum) in
a humidified atmosphere of5% C02 and 95%air. For preparative purposes, cells
were grown in suspension culture using complete Eagle's medium (Eagle's
medium with Eagle's salts, supplemented with 1596 horse serum and 2.5% fetal
calf serum). Production of PRL and GH by different cell strains was measured
after harvesting cells grown to the same density in fresh medium for identical
periods oftime.
Isolation of 928-9b GH Cell Strain
Isolation of 928-9b involved preparation of a nuclear monolayer of one ofthe
parent cell lines by adopting the method described by Mauck and Green (14).
These authors demonstrated that when 3T6cells in monolayer were subjected to
mild detergent treatment, the cytoplasm leaked out but the nuclei remained
attached to the plate forming a monolayer of nuclei which was referred to by
these authors as a "Ghost monolayer." Such nuclei maintain RNA and DNA
synthesis at a level comparable to that ofintact cells for several hours (3, 14). A
nuclear monolayer was prepared from the PRL-, F,BGH,2C, cells by treatment
of the cells (grown in 60-mm dishes, in F10 medium, approximately 106/plate)
with 0.1% Nonidet-P 40 (Shell Oil Co., Houston, Tex.) for 30-45 s at room
temperature. The nuclear monolayer was then washed three times very gently
with serum minus minimal essential medium. Atypical electron micrograph of
such a nuclear monolayer isshown in Fig. 1. Approximately 5 x 106ofthe PRL',
GHaC, cells (the other parent) in 2-3 ml of Fl0 medium was then overlayered on
the sameplatecontainingthis nuclearmonolayer. Theplates were then incubated
under normal cell growth conditions, to permit the GH4C, cells to attach. After
this period, medium was removed and polyethylene glycol (PEG) mediated
fusion under the conditionsdescribed by Davidson andGerald (7)was conducted.
Theplates were then washed free of PEGand incubated for 48 h in F10 medium.
During this period the plates were examined under a phase-contrast microscope
and cells with multiple nuclei were observed. Control plates in duplicate, con-
taining either nuclear monolayer alone or GH4C, cells alone were subjected to
similar treatments. After this period, 3 ml of selection medium (F 10 + 30 pg/ml
BrdUrd) was added to both control and experimental plates, and plates were
incubated for 72 h. No survivors were noticed in the control plates (less than one
in 106 cells). However, 10-15 colonies were located in the experimental plates.
Spontaneous
TABLE I
Certain Properties of Different GH Cell Strains
The 928-9b strain, whose properties have been studied in this investigation, is
one ofthem.
Karyotype Analysis
Karyotype analysis of the two parent strains and that of 928-9b was carried
out by following the method described by Steve Mento (1979, Ph.D. thesis,
Rutgers University). Cells in exponential growth were treated with 1 pg/ml of
colcemid and incubated for 3 h. Thecells were centrifuged (1,000 g, 5 min) and
5 ml of hypotonic buffer was added to the pellet which was then incubated at
37'C for 5 min. The cellpelletobtained after centrifugation ofthis cellsuspension
was fixed with 1 ml of fixative (one part acetic acid: three parts methanol). Two
to three drops of the mixed suspension were then placed onto a clean glass slide
and the slide was thrust through a flame to ignite the fixative. This step was
repeated two to three times. Theslide was washed in absolute alcohol, dried, and
subsequently treated in 1 N HCl at 60°C for 10 min. The slide was stained with
Giemsa and destained by sequential treatment with acetone, acetone:xylene (1:
1), and xylene. Sets of chromosomes of 100 different cells were counted for each
cell strain.
Assays for PRL and GH Production
and Synthesis
Theproduction ofPRLand GH was measured by microcomplement fixation
assay of the culture media and sonic extracts of cells (18). PRL synthesis was
quantitated by indirect antibody precipitation of PRL in culture media and in
cells after pulsing for 6 h with ['Hlleucine. Aliquots of cell lysates or media
samples were brought to 0.5 ml in 0.15 M NaCl, 0.01 Msodium phosphate, pH
7.5, 1% Triton X-100, 0.1% leucine. After centrifugation in an Eppendorf micro-
fuge, prolactin was indirectly immunoprecipitated from the supernatent by the
addition of5 Al of a diluted rabbit anti-PRL antiserum, incubation at 37°C for
1 h and subsequent addition of an appropriate volume of sheep anti-rabbit
globulin (Grand Island Biological Co., Grand Island, N. Y.). After overnight
incubation at4°C, immunoprecipitates were collected, washed, and prepared for
liquid scintillation counting and NaDodS04-polyacrylamide gel electrophoresis
as described previously (1). Gels were sliced into 2-mm sections, treated with 0.5
ml of 50%Protosol (New England Nuclear, Boston, Mass.) in toluene overnight
at 37'C and radioactivity was determined in the samples after the addition of 5
mlofOmnifluor (New England Nuclear). Radioactivity inthePRLand pre-PRL
regions of the gel, usually 95% of the antibody-precipitated radioactivity, was
used to calculate the quantity of PRLsynthesized during the 6-h pulse.
Isolation of polysomes, RNA, and poly(A) RNA by oligo (dT) cellulose
chromatography has been described previously (3, 4). Poly(A) RNA, isolated
from polysomes, was translated in a cell-free system prepared from a nuclease-
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The GH strains, GH3 and GH,2C, were obtained as independent cultured lines from the pituitary tumor (13) . The GH.C, strain that produces the highest
amounts of PRL (+++) is a spontaneous derivative of GH3 (++) . The GH,2C, strain an'd F,BGH,2C,, a BrdUrd' (5-bromodeoxyuridine resistant) derivative of
GH,2C, (1) do not produce any detectable PRL (-). Both F,BGH,2C, and GH,2C, produce significant amounts of PRL after treatment with BrdUrd. The GH
strain, 928-9b, was isolated by fusion of a nuclear monolayer derived from the F,BGH,2C, strain with GH4C, cells by the method described in Materials and
Methods. "?" Stands for several questions posed in regard to different properties of the 928-9b strain.
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PRL induction Yes Yes ? No No
GH inhibition Yes Yes ? No No
BrdUrd response:
PRL induction No No Yes Yes
GH induction No No No NoFicURE 1
￿
Electron micrograph of nuclear monolayer of F,BGH22C, cells . Nuclear monolayers were prepared from the PRL-
F,BGH,2C, parent cells after brief detergent treatment as described in Materials and Methods . Electron micrograph prepared by
Evelyn Flynn through the courtesy of Dr. George Szabo . X 4,500.
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mRNA concentrations in the linear response range of the lysate assay. After a
90-min incubation period at 26°C, samples were analyzed for pre-PRL by the
indirect immunoprecipitation method described above.
Preparation of cDNAPRL and Molecular
Hybridization Assays
cDNAPRI, was prepared from the RNA of a PRL-producing GH cell strain
and isolated after hybridization to RNA from PRL-, GH cells, as described
previously (4). cDNAPR,, preparations were routinely characterized by alkaline
sucrosegradient analysis andpolyacrylamide gel electrophoresis. Highly enriched
(>75%) mRNAPRL was prepared and characterized by following the method
described previously (4). These cDNA,"RL preparations back hybridized to pure
mRNAPR,, with an eRot2 of 0.008. When hybridized to total RNA from PRL'
cells to an eRtof50, a single transition wasobserved. Under thesame conditions,
there was no significant hybridization of cDNAPRI, to RNA from the PRL-
substrain used for cDNAP,, preparation (4).
RNA excess hybridizations were carried out in plastic conical tubes using
1,000-3,000 cpmof [''HlcDNAPRL and 0.1-10 pg ofRNAin a total volume of 25
ul hybridization buffer (0.l M HEPES, pH 7.0, 0.6 M NaCl, 0.005 M EDTA).
Samples were overlayered with mineral oil, heated to 100'C for 1 min, and
incubated at 68'C for various times. The reactions were terminated by freezing
in a dry ice-methanol bath. The degree of hybridization was assessed after S,
nuclease (Boehringer Mannheim Biochemicals, Indianapolis, Ind.) treatment
(37'C for 30 min) and subsequent trichloroacetic acidprecipitation ofS,-resistant
hybrids. When hybridization was observed, >95% of the cDNAp,, was involved
in hybrid formation.
PRL-RNA sequences were determined from the eRot,i2 values ofthe hybrid-
ization curves generated by plotting percent hybridization as a function of eRot.
eRt = RNA concentration (moles of nucleotide per liter) x time (seconds)
corrected to standard reaction conditions.
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FIGURE 2 Growth characteristics of GH cells. The two parent
strains, GH4C, and F,BGH12C,, and the 928-9b derivative were
grown in complete medium (F10, 2 ml) in 35-mm dishes (Falcon
Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.) in the
absence (") and in the presence (O) of 3011g/ml BrdUrd. Plates
were withdrawn after every 2 d of growth, and washed free of
medium. Cells were scraped off the plate with 2 ml of 0.1 NaOH
and protein in an aliquot was determined by the method of Lowry
et al. (12). Each point represents an average of protein determina-
tions in duplicate plates.
TABLE II
RESULTS
Karyotype Analysis of GH Cell Strains
The new GH cell strain, 928-9b, was isolated after fusion of a
nuclear monolayer of one GH strain to intact cells of another
GH strain. The nuclear monolayer, prepared by detergent
treatment of F,BGH12C, cells (described in Materials and
Methods) retained elements of cytoskeleton structure (Fig. 1).
No surviving cells (less than one in 106) could be detected
when the nuclear monolayers or GH4C1 cells alone were sub-
jected to identical fusion and selection in the presence of
BrdUrd (30 jg/ml). Several properties of 928-9b described
below are distinctly different from either of the parent strains
from which it is derived. Nuclear monolayers were preferred
for the fusion so that inability to survive could be exploited for
selection purposes. After selection, 928-9b cells were compared
to the parent GH strains with respect to growth pattern and
chromosome number, and then used in studies of regulated
PRL gene expression. All parameters of PRL gene expression
in these three strains were quantitated under identical growth
conditions.
Growth Pattern and Karyotype Analysis
The growth of GH4C1, 928-9b, and FIBGH12C1 cells in the
absence and presence ofthe drug, BrdUrd (30 ttg/ml) has been
studied. Results presented in Fig. 2 show that the growth
pattern of 928-9b is comparable to that of both parent strains
in the absence of the drug. The 928-9b cells, as well as the
BrdUrd' parent, F,BGH22C1, can grow in the presence of
BrdUrd (30 ttg/ml). The growth pattern of the 928-9b strain
was studied after culturing cells in the absence of the drug for
several generations, and then reexposing cells to the drug. The
fact that the growth of these cells was similar whether or not
the drug was present demonstrates that the drug resistance
property of these cells is a stable phenotype and that the cells
are not dependent on BrdUrd for growth.
Karyotype analysis demonstrates that 928-9b cells contain
an average of 70 chromosomes/cell, which is significantly
higher than that of the PRL+ and PRL- parent strains (63 and
57, respectively, Table 11). The number of chromosomes and
the characteristic phenotype described below have been found
to be constant over the last 6-12 mo of continuous culture,
suggesting that these features of the new cell line, 928-9b, are
stable ones.
PRL and GH Production at the Basal State and
in Response to TRH
As previously demonstrated (1) for parent strains, 928-9b
cells do not store PRL intracellularly (data not shown). Fur-
thermore, there is very little degradation of PRL in the culture
media of GH cells under these growth conditions (5). There-
The karyotypes of the three strains were examined as described in Materials and Methods. The number in parentheses designates the number of sets of
chromosomes counted for each cell type.
* The significance of difference between the three average numbers of chromosomes was calculated by X' analysis with twodegrees of freedom. The P value has
been found to be <0.001 .
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Strains 50-54 55-59 60-64
No.
65-69
% cells
chromosomes
70-74
counted
75-79 80-84 85-89
Average No.
chromosomes
F1 BGH1 2C7 (100) 38 32 17 13 - - - - 57
GH4C1 (100) 3 22 36 32 7 - - - 63
928-9b (100) - - 14 35 26 16 8 1 70*fore, the measurement of PRL in the medium reflects PRL
production, i.e., the net PRL synthesized and secreted by the
cells within a specific period of time. PRL synthesis in these
cells, on the other hand, is measured as anti-PRL antibody
precipitable radioactivity after pulse labeling the cells with
[3H]leucine.
The results presented in Fig. 3 show the production on PRL
by GH4C,, F,BGH12C,, and 928-9b cells at the basal stateand
after treatment with TRH. 928-9b cells synthesize and secrete
into the medium an amount of PRL (2-4 Ag/mg protein/24 h)
which is about 5- to 10-fold lower than the PRL+, GH4C1 cells
(15-25 jLg/mg protein/24 h) and substantially higher than the
PRL-, F,BGH12C, cells in which PRL could not be detected
in the medium either by complement fixation assay (sensitivity
level of 0.005 jLg/ml) (Fig. 3A) or by precipitation with anti-
PRL antibody from the total radioactive proteins of cells
labeled with [3H]leucine for 6 h (data not shown). These results
demonstrate that PRL synthesis in three GH strains follows the
order GH4C1 > 928-9b > F,BGH,2C,, thus reflecting a gra-
dation in the basal synthesis of a cell-specific protein.
GH is another cell-specific protein that is synthesized by all
three GH cell strains. GH production by 928-9b (0.4-0.6 ftg/
mg protein/24 h) is not substantially different from GH pro-
duction observed in either of the two parent strains (0.7-0.8
gg/mg protein/24 h) (Fig. 3 B).
TRH stimulation ofPRL synthesis in GH4C, cells is evident
from the results presented in Fig. 3A ("). Maximal stimulation
of PRL synthesis in GH4C1 cells was seen at TRH concentra-
tions ranging between 5 and 10 ng/ml. When examined under
identical growth conditions, the PRL-, FIBGH12C, cells (Fig.
3A, A), do not respond to TRH at concentrations ranging from
0.1-100 ng/ml. Although 928-9b produced substantial amounts
of PRL, its synthesis could not be further stimulated over the
basal level by treatment with TRH at concentrations ranging
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from 0.1-100 ng/ml (Fig. 3A, O). Treatment of F,BGH,2C,
cells and 928-9b cells with 10 ng/ml TRH for as long as 8 d
did not stimulate PRL synthesis in either strain. TRH at these
concentrations has no effect on the growth rate of any of these
cells.
Results presented in Fig. 3 B show GH production by the
three GH strains. Treatment of the GH4C1 parent with TRH
inhibited GH production to the extent of 72% ("). However,
no effect of TRH could be observed in either 928-9b (O) or in
the FIBGH12C, (A) parent cells. These results show that,
among the three strains, only the PRL+ parent, GH4C1, re-
sponds to TRH with regard to stimulation of PRL synthesis
and inhibition of GH synthesis.
TRH-specific Receptor
Results presented in Table III show 3H-TRH binding to
GH4C,, F,BGH12C,, and the 928-9b cells. It is evident from
these results that the PRL+, GH4C1 strain and 928-9b, specifi-
cally bind 3H-TRH whereas the PRL-, F,BGH12C, cells do
not demonstrate any specific 3H-TRH binding. These results
indicate that GH4C1 and 928-9b cells contain specific TRH
receptors and, as previously shown (1), the F,BGH,2C, cells
do not contain specific receptors.
Translatable mRNA PRL Levels
To examine the possibility that amounts of PRL synthesized
by the three GH cell strains is a reflection of corresponding
amounts of cytoplasmic translatable mRNAPRL, the amount of
mRNAPRL in the cytoplasm of the three strains has been
quantitated. It is evident from the results presented in Table
IV that the GH4C1 (PRL+) strain contains the highest amounts
of translatable mRNAPRL when compared to 928-9b and
FIBGH12C, cells. Although the amount of translatable
B. GROWTH HORMONE
G H4
rl, 7
L
FIGURE 3
￿
Effect of TRH on PRL and GH synthesis in GH cells. GH cells were grown in F10 medium (4 ml) in 60-mm Falcon
Labware tissue culture dishes, in the presence of indicated concentrations of TRH. Medium was withdrawn from the plates after
4 d of growth under these conditions, and PRL (A) and GH (8) in the medium were determined by microcomplement fixation
assay (18). The cells in the dishes were washed free of medium and protein in the cell suspension was determined as described in
the legend to Fig. 2. Each point represents an average of determinations of hormone concentrations in medium withdrawn from
duplicate plates. (a) PRL content in GH4C, ("), in 928-9b (O), and FIBGH12C, (A) ; (8) GH4C, ("), 928-9b (O), and F,BGH12C,
(A) .mRNAPRL in the cytoplasm of 928-9b cells could not be exactly
determined because of inaccuracy in quantitating low levels of
anti-PRL antibody precipitable radioactivity, the translatable
mRNAPRL assayed on several occasions was always higher
than 0.1% and lower than 1% of the total. No anti-PRL
antibody precipitable radioactivity was ever detected in the
PRL-, F1BGH12C1 strain. These findings, which suggest that
the 928-9b cells synthesize a constant low level of mRNAPRL
and that PRL- cells do not contain any mRNAPRL, were
further substantiated by RNA/cDNAPRL molecular hybridi-
zation studies described in the following section.
After TRH treatment, the amount of translatable mRNAPRL
in the cytoplasm of PRL+, GH4C1 cells was increased substan-
tially (about threefold). The levels of translatable cytoplasmic
mRNAPRL in 928-9b cells after TRH treatment was similar to
that observed in control cells. However, the possible stimulation
of translatable mRNAPRL levels by TRH in 928-9b cells could
not be ruled out from these results because of the insensitivity
of this assay.
The quantitation of cytoplasmic translatable mRNAPRL de-
termines the amounts ofprocessed and functional PRL-specific
mRNA. However, this does not take into consideration the
nonfunctional cytoplasmic mRNAPRL sequences (if there are
any). Furthermore, the low level of mRNApRL in 928-9b could
not be accurately determined.
In consideration of these limitations of the translational
assay, the amounts of PRL produced by these cells were
correlated with their content of PRL-specific RNA sequences
by molecular hybridization assays using cDNAPRL, prepared
as described previously (4). This cDNAPRL preparation has
been found to be at least 75-80% enriched for cDNAPRL
sequences, shows a single transition with an eRotliz of 0.008
when hybridized to highly enriched mRNAPRL (95% of the
translatable mRNAPRL preparation encoded for PRL) and
displays no hybrid formation with mRNA preparations from
the PRL- strain, GH12C1.
The cytoplasmic poly(A)-containing RNA from the
FlBGH12C,, (PRL-) strain, did not react with cDNAPRL even
when hybridized to an eRat value of 10 (Table IV). This is
consistent with the results reported in Fig. 3 and Table IV,
which show that FIBGH12C, cells do not produce detectable
amounts of PRL (<0.005 jig/ml) and do not contain any
TABLE III
3H-TRH Binding to Parent and Hybrid Cell
'H-TRH binding to cells in monolayer was carried out according to the
method described by Hinkle and Tashjian (10). Each cell type was grown in
four dishes (35 mm) in F10 medium to the semiconfluent state. The plates
were rinsed with fresh pre-equilibrated F10 medium on the day of the
experiment. 1 ml of fresh medium containing 25 nM 3H-TRH (0.5 tLO) was
added to all four plates of each cell type. Nonradioactive TRH was then added
to two of the four plates to achieve a final concentration of 25 /AM (excess) to
determine the nonspecific binding. All the plates were then incubated at
37'C (5% COz and 95% air) for 1 h. After this period of incubation, the
medium was removed by gentle suction and the cells were washed with
chilled (4°C) phosphate buffered saline five times. To the washed plates, 1 ml
of 0.1 N NaOH was added. An aliquot of the lysed cells was then taken in 10
ml of Aquasol (New England Nuclear) and counted in a liquid scintillation
counter. Protein was determined in another aliquot of the same lysed cell
suspension by the method of Lowry et al (12).
detectable translatable mRNApRL. In contrast, cytoplasmic
poly(A) RNA from control and TRH-treated GH4C1 (PRL+)
cells, hybridized rapidly to cDNAPRL with pseudo-first-order
kinetics (Fig. 4). TRH treatment resulted in an approximately
2.5 fold increase in the percent of PRL-RNA sequences in
these RNA preparations (Table IV). This result parallels the
observations in the case of translatable mRNAPRL from control
and TRH-treated cells.
Similar to the lower PRL production levels and lower trans-
latable mRNAPRL observed when 928-9b cells were compared
to the PRL+, GH4C1 cells, cytoplasmic poly(A) RNA from
928-9b cells contained about fivefold fewer PRL-RNA se-
quences (Table IV). In agreement with the observation that
TRH does not alter PRL production levels and does not cause
TABLE IV
Translatable mRNAPRL Levels and Cytoplasmic mRNAPRL
Sequences in the Parents and in the Hybrid GH Cell Strain
Translatable mRNAPRL
￿
mRNAPRL sequences
Poly(A)-RNA was isolated from polysomes of the various cell strains by
following the procedures described previously (4), and translated in a cell-
free system prepared from reticulocyte lysates (16). After incubation at 26'C
for 90 min, the amount of pre-PRL synthesized was determined by indirect
immunoprecipitation as described in Materials and Methods.
* Amounts of radioactive pre-PRL identified in the cell-free system primed
with poly(A)-RNA from 928-9bcells were very low, and the absolute amount
could not be accurately determined. In repeated experiments, the amount
of pre-PRL detected ranged between 0.1 and 1% of the total proteins
synthesized. The PRL sequences of cytoplasmic poly(A)-RNA samples were
determined by molecular hybridization to cDNAPRL as described in Materials
and Methods. eR,,t2 values for hybridization were extrapolated from the
hybridization curve shown in Fig. 4, and PRL-mRNA sequences were quan-
titated by using a standard curve generated by hybridization of cDNAPgL to
mRNAPRL under conditions identical to those described previously (4).
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Effect of TRH on hybridization of cDNAPRL to cytoplas-
mic poly(A) RNA in GH cell strains. Molecular hybridization of
cDNAPRL to Cytoplasmic poly(A) RNA samples was determined as
described in Materials and Methods. Percent hybridization was
assessed after S, nuclease treatment and comparison of S,-resistant
radioactivity in hybridized samples to radioactivity in cDNAPRL
controls that did not receive S, treatment. S,-resistant radioactivity
in cDNAPRL preparations (5% of total) was subtracted from control
and sample values before plotting percent hybridization. Each point
on the curve represents average of duplicate determinations. Cyto-
plasmic poly(A) RNA from GH4C, (O), GH4C, + TRH cells ("), 928-
96 cells (A), and 928-96 + TRH cells (A).
Strain Total
3H-TRH bound
Nonspecific
cpm/mg protein
GH4C, 65,558 2,297
F,BGH 1 2C, 2,523 3,171
928-9b 72,600 2,400
Strains -TRH
% total
translatable
+TRH
RNA
-TRH
% total
poly(A)
+TRH
cytoplasmic
RNA
GH4C, 2 6.4 0.58 1 .85
928-9b 0.1-1* 0.1-1* 0.19 0.15
F,BGH,2C, 0 0 0 0majorchangesin translatable mRNAPRLlevels, TRH treatment
of 928-9b cells did not affect the quantity of cytoplasmic
poly(A) PRL-RNA sequences (Table IV). The eRot,/2 values
(Fig. 4) from which the percent PRL-RNA sequences were
calculated in the case of control and TRH-treated 928-9b cells
are not significantly different from each other.
These resultsdemonstrate that thedifferentamountsofPRL
synthesized and different levels of translatable mRNAPRL ob-
served in these three GH strains is a reflection of the different
levels of PRL-specific mRNA produced by these cells. Simi-
larly, the stimulation of PRL synthesis by TRH in PRL+,
GH,C, cells, is also caused by increased production of cyto-
plasmic PRL-specific mRNA sequences.
DISCUSSION
DifferentGH strainsexpressthe PRLgene to different degrees,
thus providing a system to determine the point/s of control of
the regulated expression of a specific gene in eukaryotic cells.
The primary objective of this investigation was to determine
the level of PRL gene expression in a cell strain derived from
fusion of genetic elements from a strain that produces large
amounts of PRL and a strain in which PRL production is
undetectable. Results presented in this investigation demon-
strate that 928-9b, the strain isolated by fusion of PRL+,GH4C1
cells with a nuclear monolayer of PRL-, F,BGH,2C1 cells,
shares properties with both parents. Like the GH4C1 parent
(PRL+), 928-9b cells (a) produce a constant amount of PRL
(b) do not retain PRL inside the cell, but rather secrete almost
all of the newly synthesized PRL into the media, (c) contain
TRH-specific receptors, and (d) cannot be stimulated to pro-
duce increased PRL by the drug, BrdUrd. Resembling the
PRL- parent strain, 928-9b cells are (a) resistant to the drug,
BrdUrd, and (b) do not respond to TRH.
In contrast to these similarities, 928-9b cells also display
several phenotypes that are distinctly different from either of
the parent strains: (a) the basal level production of PRL is
about 5- to 10-fold lower than the PRL+ parent, but signifi-
cantly higher than the PRL- strain, (b) the number of chro-
mosomes in these cells (Table II) is significantly higher than
that ofeither parent, (c) unlike the PRL+ strain, PRL synthesis
cannot be further modulated by TRH, and unlike the PRL-
parent strain, PRL synthesis cannot be stimulated by BrdUrd.
These observations suggest that the 928-9b cells inherited
genetic elements from both parents and display characteristics
which appear to represent a composite of traits from both
parents.
This investigation has utilized the PRL+ and the PRL-
parent strains and the newly isolated GH strain, 928-9b, to
locate the point/s of control of PRL gene expression at the
basal level and after treatment with TRH. These studies re-
vealed that graded PRL production by these cells (GH4CI >
928-9b > F,BGH12C,) could be correlated with cytoplasmic
translatable mRNAPRL and PRL-RNA sequences in cytoplas-
mic poly(A) RNA.
A similar finding was observed with regard to PRL gene
expression in the parent and in 928-9b strains in response to
TRH. Increased PRL synthesis in the PRL+, GH4C1 cells,
could be closely correlated with increased mRNAPRL as well as
increased PRL-RNAsequencesin the cytoplasm. In the PRL-,
FIBGH,2C, strain,whichdoes notrespondto TRH, mRNAPRL
and PRL-RNA sequences in cytoplasmic RNA fractions re-
mained undetectable before and after TRH treatment. 928-9b
cells, which producelower levels of PRL than thePRL+ parent
12
￿
THE JOURNAL Of CELL BIOLOGY - VOLUME 87, 1980
strain, do not respond to TRH. In the 928-9b strain, TRH did
not alter cytoplasmic poly(A) PRL-RNA sequences from con-
trol values.
Taken together, the above observations suggest that control
of graded PRL-gene expression in the two parents and in the
hybrid GH strain at the basal state and after treatment with
TRH is exerted at a point before the appearance of PRL-
mRNA sequences in the cytoplasm, most probably at the level
of transcription. However, possible regulation at the level of
post-transcriptional steps is not completely eliminated. Such
transcriptional modulation of cell-specific protein synthesis in
response to the hormone estrogen has been demonstrated by
other investigators (19, 20).
The peptide hormone, TRH, exerts its effect on cell-specific
protein synthesis via an initial interaction with a specific class
of plasma membrane receptors. After the initial hormone re-
ceptor complex formation, the resulting signal is transmitted
by some as yet unknown mechanism/s. The action of the
hormone eventually results in altered PRL and GH synthesis.
The 928-9b strain, isolated in this investigation, possesses spe-
cific TRH receptors, but does not respond to TRH with regard
to this hormone's biological effect on PRL and GH synthesis
(Fig. 3). The TRH receptor itself may be responsible for this
effect, forexample by exhibiting altered affinity for TRH. Such
anomalies in receptor properties have been described for in-
sulin receptors in various diseases (For review, see reference
11 .). However, in this strain, initial hormone receptor complex
formation appearsto be uncoupled from thesequence ofevents
leading to the effect ofTRH on PRL and GH gene expression.
This suggests a defect in the step/s subsequent to hormone
bindingso that even though hormonereceptor interaction takes
place as in the GH4CI parent strain, no transmission of the
signal follows. Such defects have been observed in corticotropin
stimulation of adrenal steroidogenesis (17). The new GH cell
strain, 928-9b, described in this investigation may be an ideal
cell system forexaminingthe role ofpeptidehormonereceptors
and processes subsequent to hormone-receptor interaction on
the modulation of the expression of a specific gene.
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